Veracyte, Inc. (VCYT)

Veracyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	217.33	155	173.95	349.97	159.92
Short-Term Investments	0	24.61	3.96	0	0
Cash & Cash Equivalents	217.33	179.6	177.91	349.97	159.92
Cash Growth	21.01%	0.95%	-49.16%	118.84%	103.47%
Receivables	40.38	44.02	41.46	18.46	19.33
Inventory	16.13	14.29	11.23	4.66	6.81
Other Current Assets	11.79	10.72	12.51	2.59	1.63
Total Current Assets	285.62	248.64	243.1	375.68	187.69
Property, Plant & Equipment	30.86	30.86	31.14	16.83	17.74
Goodwill and Intangibles	791.58	870.76	910.64	62.65	67.74
Other Long-Term Assets	6.85	6.17	2.95	2	2.04
Total Long-Term Assets	829.29	907.79	944.72	81.48	87.53
Total Assets	1,115	1,156	1,188	457.16	275.21
Accounts Payable	12.94	11.91	12.36	3.12	2.33
Deferred Revenue	2.01	2.61	4.99	1.2	0
Current Debt	5.11	4.07	4.76	1.59	1.41
Other Current Liabilities	41.19	44.02	42.05	10.88	13.73
Total Current Liabilities	61.24	62.61	64.15	16.78	17.47
Long-Term Debt	7.53	10.65	14.1	10.73	12.2
Other Long-Term Liabilities	2.04	7.96	13.06	8.42	6.09
Total Long-Term Liabilities	9.56	18.61	27.16	19.15	18.29
Total Liabilities	70.8	81.22	91.31	35.93	35.76
Total Debt	12.63	14.72	18.85	12.32	13.61
Debt Growth	-14.19%	-21.93%	53.08%	-9.49%	-46.18%
Retained Earnings	-468.12	-393.72	-357.16	-281.59	-246.69
Comprehensive Income	-24.02	-31.35	-15.08	0	0
Shareholders' Equity	1,044	1,075	1,097	421.23	239.46
Net Cash / Debt	204.7	164.88	159.06	337.65	146.31
Net Cash / Debt Growth	24.15%	3.66%	-52.89%	130.77%	174.43%
Net Cash Per Share	2.82	2.30	2.34	6.34	3.17
Working Capital	224.38	186.02	178.95	358.9	170.22
Book Value Per Share	14.37	15.03	16.15	7.91	5.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).